Tequin Recent News - FindLaw
Created by FindLaw's team of legal writers and editors| Last reviewed June 20, 2016
August 29, 2006: Consumer Group Urges Antibiotic Warnings
Public Citizen, a national non-profit consumer advocacy organization, petitioned the U.S. Food and Drug Administration (FDA) to immediately add a "black box" warning to product labels of all fluoroquinolone antibiotics on the U.S. market -- including Tequin - advising health care providers and patients on risks of tendinopathy and tendon rupture associated with these drugs. Public Citizen states that from November 1997 through 2005, the FDA received reports of 262 cases of tendon rupture in patients using fluoroquinolone antibiotics. See the Public Citizen Press Release.
May 9, 2006: Class-Action Lawsuit Against Tequin Manufacturer
A class-action lawsuit was filed in Canada against Bristol-Myers Squibb, the makers of Tequin, alleging that it failed to warn patients about the risks associated with the drug. One of the plaintiffs alleges that he fell into a coma after taking three doses of Tequin, was hospitalized for seven months, and now requires medical care for the rest of his life.
May 2, 2006: Bristol-Myers Squibb Will Stop Selling Tequin
Bistrol-Myers Squibb Company announced during a conference call with investors that it will stop manufacturing and selling Tequin. The company said that it has decided to return the rights to the drug to Japan-based Kyorin Pharmaceutical Company. Bristol-Myers Squibb has not pulled Tequin off the shelf completely, and it urges Tequin users to see their physicians before they stop taking the antibiotic.
May 1, 2006: Public Citizen Calls on FDA to Ban Antibiotic Tequin
Public Citizen, a national non-profit consumer advocacy organization, petitioned the U.S. Food and Drug Administration (FDA) to ban Tequin, stating that the antibiotic causes an increased risk of blood sugar problems and has caused deaths and hospitalizations. While manufacturer Bristol-Myers Squibb Company has changed Tequin labeling to address the increased risks associated with the drug, Public Citizen has urged that nothing short of a complete ban on Tequin will ensure public safety. See the Public Citizen press release.
March 2006: U.S. Food and Drug Administration (FDA) Announces New Tequin Labeling
The FDA issued an alert stating that on February 15, 2006, Bristol-Myers Squibb Company revised Tequin labeling because Tequin has caused some people to have serious blood sugar problems. Click here to read the full FDA alert.